Back to top
more

IDEXX Laboratories (IDXX)

(Real Time Quote from BATS)

$416.80 USD

416.80
268,596

-6.85 (-1.62%)

Updated Nov 15, 2024 01:04 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 26% (65 out of 250)

Industry: Medical - Instruments

Zacks News

Zimmer Biomet (ZBH) Hurt by EMEA's Slow Recovery Amid Pandemic

Zimmer Biomet's (ZBH) leveraged capital structure is an added concern.

Quidel's (QDEL) QuickVue OTC COVID-19 Test Now Widely Available

In-store and online availability of Quidel's (QDEL) QuickVue OTC COVID-19 Test is expected to meet the rising COVID-19 testing needs across the United States.

Thermo Fisher (TMO) Gains Government Contract for Pipette Tip

Thermo Fisher (TMO) will co-invest with the U.S. government to build a new manufacturing center for pipette tips in North Carolina.

Sapna Bagaria headshot

Hold Petco (WOOF) as It Rides on Continued Demand for Pet Care

Petco (WOOF) by dint of its wide product and services portfolio, omni-channel presence and strategic initiatives is well poised to cash in on the expanding petcare industry.

AMN Healthcare (AMN) Hits 52-Week High: What's Behind It?

Investors are optimistic about AMN Healthcare's (AMN) broad array of services.

Veeva (VEEV) MedTech Suite to Aid B. Braun Speed Up Trials

Adoption of Veeva's (VEEV) unified suites of cloud applications is likely to provide a significant boost to the company's Veeva Development Cloud business.

The Zacks Analyst Blog Highlights: Varex Imaging, Omnicell, STAAR Surgical and IDEXX Laboratories

The Zacks Analyst Blog Highlights: Varex Imaging, Omnicell, STAAR Surgical and IDEXX Laboratories

BD's (BDX) Latest Diagnostic System to Improve Lab Efficiency

BD's (BDX) new system is expected to address labs' needs for high-volume processing and increases in efficiency.

Urmimala Biswas headshot

4 MedTechs to Gain in 2H21 Beating the Delta Variant-Led Dip

Investors can choose to invest in MedTech stocks like VREX, OMCL, STAA, and IDXX that have shown tremendous promise amid the pandemic.

Stock Market News for Aug 31, 2021

The S&P 500 and the Nasdaq closed at record highs on Monday as investors flocked to technology and consumer discretionary shares, after the Federal Reserve¿¿¿s dovish stance on tapering its monetary stimulus last week.

Idexx (IDXX) is an Incredible Growth Stock: 3 Reasons Why

Idexx (IDXX) possesses solid growth attributes, which could help it handily outperform the market.

Reasons to Hold on to Veeva Systems (VEEV) Stock For Now

Investors continue to be optimistic about Veeva Systems (VEEV) on its slew of partnerships and robust product adoptions.

Here's Why You Should Retain Integra (IART) Stock for Now

Solid performance across the CSS and Tissue Technologies segments is driving the top line for Integra (IART).

Thermo Fisher's (TMO) Oncomine Dx Gets CDx Approval for TIBSOVO

Thermo Fisher (TMO) receives FDA go-ahead for the Oncomine Dx Target Test as a CDx for Servier's ivosidenib tablets, TIBSOVO.

SmileDirectClub (SDC) Reels Under Rising Costs, Debt Woes

SmileDirectClub (SDC) sees net operating cash outflow in the second quarter.

BD (BDX) Veritor At-Home COVID-19 Test Receives EUA From FDA

EUA for BD's (BDX) At-Home COVID-19 test is expected to boost home testing to prevent outbreaks and limit the rise in COVID-19 cases from the Delta variant.

Here's Why You Should Retain BD (BDX) Stock in Your Portfolio

Investors continue to be optimistic about BD (BDX) owing to its slew of product launches and regulatory approvals.

Here's Why You Should Invest In Tandem Diabetes (TNDM) Now

Continued adoption of Tandem Diabetes' (TNDM) t:slim X2 technology and international expansion of the Control-IQ technology add to the company's solid second-quarter performance.

Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year?

Is (IDXX) Outperforming Other Medical Stocks This Year?

Here's Why You Should Retain Masimo (MASI) Stock For Now

Investors continue to be optimistic about Masimo (MASI) owing to its slew of product launches and regulatory approvals.

Here's Why You Should Retain PacBio (PACB) Stock For Now

Investors continue to be optimistic about PacBio (PACB) owing to its slew of strategic deals and strength in its Sequel system.

Here's Why You Should Add IDEXX (IDXX) to Your Portfolio Now

Investors are optimistic about IDEXX (IDXX) on strong growth in CAG business and raised 2021 outlook.

Petco (WOOF) Q2 Earnings Beat on Continued Demand for Pet Care

Petco (WOOF) Q2 earnings exceed estimates on buoyant demand for pet care products and services.

Intuitive Surgical (ISRG) Hits 52-Week High: What's Behind It?

Investors are optimistic about Intuitive Surgical's (ISRG) strength in its da Vinci surgical system.